Stevanato Group S.p.A. (NYSE:STVN) Shares Bought by Fred Alger Management LLC

Fred Alger Management LLC raised its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 24.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,070,557 shares of the company's stock after buying an additional 208,830 shares during the quarter. Fred Alger Management LLC's holdings in Stevanato Group were worth $21,411,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Hardy Reed LLC increased its holdings in shares of Stevanato Group by 8.2% in the third quarter. Hardy Reed LLC now owns 11,077 shares of the company's stock valued at $222,000 after purchasing an additional 840 shares during the last quarter. Hilltop National Bank increased its stake in shares of Stevanato Group by 34.3% in the 2nd quarter. Hilltop National Bank now owns 4,395 shares of the company's stock worth $81,000 after acquiring an additional 1,122 shares during the last quarter. Lindenwold Advisors INC raised its holdings in shares of Stevanato Group by 13.5% during the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company's stock worth $239,000 after acquiring an additional 1,415 shares during the period. Captrust Financial Advisors boosted its position in shares of Stevanato Group by 12.7% during the 3rd quarter. Captrust Financial Advisors now owns 13,100 shares of the company's stock valued at $262,000 after acquiring an additional 1,480 shares during the last quarter. Finally, Raymond James Trust N.A. grew its holdings in shares of Stevanato Group by 18.7% in the second quarter. Raymond James Trust N.A. now owns 10,239 shares of the company's stock valued at $188,000 after purchasing an additional 1,613 shares during the period.

Stevanato Group Trading Up 0.2 %

Shares of NYSE STVN traded up €0.03 ($0.03) during mid-day trading on Friday, reaching €20.03 ($21.08). 144,700 shares of the company's stock were exchanged, compared to its average volume of 508,631. The firm has a market capitalization of $5.92 billion, a price-to-earnings ratio of 42.62, a PEG ratio of 9.00 and a beta of 0.58. The company's 50-day moving average is €19.49 and its 200-day moving average is €19.62. Stevanato Group S.p.A. has a 52-week low of €16.56 ($17.43) and a 52-week high of €34.73 ($36.56). The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81.

Stevanato Group (NYSE:STVN - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million for the quarter, compared to analyst estimates of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company's revenue for the quarter was up 2.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.16 EPS. Analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Citigroup decreased their target price on shares of Stevanato Group from $30.00 to $28.00 and set a "buy" rating on the stock in a report on Wednesday, August 7th.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.